ID   CHID1_HUMAN             Reviewed;         393 AA.
AC   Q9BWS9; B3KWB0; Q8NBM9; Q96CZ3; Q96S93; Q96SK0; Q9BY52;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 149.
DE   RecName: Full=Chitinase domain-containing protein 1;
DE   AltName: Full=Stabilin-1-interacting chitinase-like protein;
DE            Short=SI-CLP;
DE   Flags: Precursor;
GN   Name=CHID1; ORFNames=GL008, PSEC0104, SB139;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH STAB1, AND TISSUE SPECIFICITY.
RX   PubMed=16357325; DOI=10.1182/blood-2005-07-2843;
RA   Kzhyshkowska J., Mamidi S., Gratchev A., Kremmer E., Schmuttermaier C.,
RA   Krusell L., Haus G., Utikal J., Schledzewski K., Scholtze J., Goerdt S.;
RT   "Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-
RT   regulated in alternatively activated macrophages and secreted via lysosomal
RT   pathway.";
RL   Blood 107:3221-3228(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-338.
RC   TISSUE=Liver;
RA   Li Y., Wu T., Xu S., Ren S., Chen Z., Han Z.;
RT   "A novel gene expressed in human liver non-tumor tissues.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Li N., Wan T., Zhang W., Cao X.;
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-338.
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLN-331
RP   AND VAL-338.
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS), TISSUE SPECIFICITY, INDUCTION,
RP   MUTAGENESIS OF TYR-84; TRP-88; TRP-110; TYR-261; TRP-277 AND TYR-302, AND
RP   FUNCTION.
RX   PubMed=20724479; DOI=10.1074/jbc.m110.130781;
RA   Meng G., Zhao Y., Bai X., Liu Y., Green T.J., Luo M., Zheng X.;
RT   "Structure of human stabilin-1 interacting chitinase-like protein (SI-CLP)
RT   reveals a saccharide-binding cleft with lower sugar-binding selectivity.";
RL   J. Biol. Chem. 285:39898-39904(2010).
CC   -!- FUNCTION: Saccharide- and LPS-binding protein with possible roles in
CC       pathogen sensing and endotoxin neutralization. Ligand-binding
CC       specificity relates to the length of the oligosaccharides, with
CC       preference for chitotetraose (in vitro). {ECO:0000269|PubMed:20724479}.
CC   -!- SUBUNIT: Interacts with STAB1. {ECO:0000269|PubMed:16357325}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:16357325}. Lysosome
CC       {ECO:0000269|PubMed:16357325}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BWS9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BWS9-2; Sequence=VSP_023825;
CC       Name=3;
CC         IsoId=Q9BWS9-3; Sequence=VSP_023826;
CC   -!- TISSUE SPECIFICITY: Expressed in cells of monocytic, T, B and
CC       epithelial origin. {ECO:0000269|PubMed:16357325,
CC       ECO:0000269|PubMed:20724479}.
CC   -!- INDUCTION: Up-regulated by IL4/interleukin-4 and dexamethasone in the
CC       macrophages. Up-regulated by glucocorticoid.
CC       {ECO:0000269|PubMed:16357325, ECO:0000269|PubMed:20724479}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 18 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BN000479; CAF32458.1; -; mRNA.
DR   EMBL; AF212229; AAK14915.1; -; mRNA.
DR   EMBL; AY037151; AAK67632.1; -; mRNA.
DR   EMBL; AK027711; BAB55316.1; -; mRNA.
DR   EMBL; AK075413; BAC11603.1; -; mRNA.
DR   EMBL; AK124697; BAG54072.1; -; mRNA.
DR   EMBL; BC000001; AAH00001.1; -; mRNA.
DR   EMBL; BC013642; AAH13642.1; -; mRNA.
DR   EMBL; BC095409; AAH95409.1; -; mRNA.
DR   CCDS; CCDS44510.1; -. [Q9BWS9-3]
DR   CCDS; CCDS44511.1; -. [Q9BWS9-2]
DR   CCDS; CCDS7722.1; -. [Q9BWS9-1]
DR   RefSeq; NP_001136146.1; NM_001142674.1. [Q9BWS9-1]
DR   RefSeq; NP_001136147.1; NM_001142675.1. [Q9BWS9-1]
DR   RefSeq; NP_001136148.1; NM_001142676.1. [Q9BWS9-2]
DR   RefSeq; NP_001136149.1; NM_001142677.1. [Q9BWS9-3]
DR   RefSeq; NP_076436.3; NM_023947.3. [Q9BWS9-1]
DR   RefSeq; XP_005253130.1; XM_005253073.4. [Q9BWS9-3]
DR   RefSeq; XP_006718345.1; XM_006718282.2. [Q9BWS9-1]
DR   RefSeq; XP_016873655.1; XM_017018166.1. [Q9BWS9-1]
DR   PDB; 3BXW; X-ray; 2.70 A; A/B=1-393.
DR   PDBsum; 3BXW; -.
DR   AlphaFoldDB; Q9BWS9; -.
DR   SMR; Q9BWS9; -.
DR   BioGRID; 122451; 80.
DR   IntAct; Q9BWS9; 1.
DR   STRING; 9606.ENSP00000398722; -.
DR   UniLectin; Q9BWS9; -.
DR   iPTMnet; Q9BWS9; -.
DR   PhosphoSitePlus; Q9BWS9; -.
DR   BioMuta; CHID1; -.
DR   DMDM; 74733460; -.
DR   EPD; Q9BWS9; -.
DR   jPOST; Q9BWS9; -.
DR   MassIVE; Q9BWS9; -.
DR   MaxQB; Q9BWS9; -.
DR   PeptideAtlas; Q9BWS9; -.
DR   PRIDE; Q9BWS9; -.
DR   ProteomicsDB; 79306; -. [Q9BWS9-1]
DR   ProteomicsDB; 79307; -. [Q9BWS9-2]
DR   ProteomicsDB; 79308; -. [Q9BWS9-3]
DR   TopDownProteomics; Q9BWS9-2; -. [Q9BWS9-2]
DR   Antibodypedia; 10139; 210 antibodies from 24 providers.
DR   DNASU; 66005; -.
DR   Ensembl; ENST00000323578.13; ENSP00000325055.8; ENSG00000177830.18. [Q9BWS9-1]
DR   Ensembl; ENST00000429789.6; ENSP00000416034.2; ENSG00000177830.18. [Q9BWS9-3]
DR   Ensembl; ENST00000436108.6; ENSP00000388156.2; ENSG00000177830.18. [Q9BWS9-1]
DR   Ensembl; ENST00000449825.5; ENSP00000391255.1; ENSG00000177830.18. [Q9BWS9-1]
DR   Ensembl; ENST00000454838.6; ENSP00000398722.2; ENSG00000177830.18. [Q9BWS9-2]
DR   Ensembl; ENST00000528581.5; ENSP00000435503.1; ENSG00000177830.18. [Q9BWS9-2]
DR   GeneID; 66005; -.
DR   KEGG; hsa:66005; -.
DR   MANE-Select; ENST00000323578.13; ENSP00000325055.8; NM_023947.4; NP_076436.3.
DR   UCSC; uc001lsm.4; human. [Q9BWS9-1]
DR   CTD; 66005; -.
DR   DisGeNET; 66005; -.
DR   GeneCards; CHID1; -.
DR   HGNC; HGNC:28474; CHID1.
DR   HPA; ENSG00000177830; Low tissue specificity.
DR   MIM; 615692; gene.
DR   neXtProt; NX_Q9BWS9; -.
DR   OpenTargets; ENSG00000177830; -.
DR   PharmGKB; PA142672118; -.
DR   VEuPathDB; HostDB:ENSG00000177830; -.
DR   eggNOG; KOG2091; Eukaryota.
DR   GeneTree; ENSGT00390000012069; -.
DR   HOGENOM; CLU_035132_2_0_1; -.
DR   InParanoid; Q9BWS9; -.
DR   OMA; YSINERI; -.
DR   OrthoDB; 1067925at2759; -.
DR   PhylomeDB; Q9BWS9; -.
DR   TreeFam; TF319271; -.
DR   PathwayCommons; Q9BWS9; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   SignaLink; Q9BWS9; -.
DR   BioGRID-ORCS; 66005; 12 hits in 1076 CRISPR screens.
DR   ChiTaRS; CHID1; human.
DR   EvolutionaryTrace; Q9BWS9; -.
DR   GenomeRNAi; 66005; -.
DR   Pharos; Q9BWS9; Tbio.
DR   PRO; PR:Q9BWS9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9BWS9; protein.
DR   Bgee; ENSG00000177830; Expressed in stromal cell of endometrium and 180 other tissues.
DR   ExpressionAtlas; Q9BWS9; baseline and differential.
DR   Genevisible; Q9BWS9; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0008061; F:chitin binding; IEA:InterPro.
DR   GO; GO:0070492; F:oligosaccharide binding; IPI:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; IDA:UniProtKB.
DR   Gene3D; 3.10.50.10; -; 1.
DR   InterPro; IPR011583; Chitinase_II.
DR   InterPro; IPR029070; Chitinase_insertion_sf.
DR   InterPro; IPR001223; Glyco_hydro18_cat.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   Pfam; PF00704; Glyco_hydro_18; 1.
DR   SMART; SM00636; Glyco_18; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS51910; GH18_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Immunity; Innate immunity; Lysosome;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..393
FT                   /note="Chitinase domain-containing protein 1"
FT                   /id="PRO_0000280608"
FT   DOMAIN          79..393
FT                   /note="GH18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01258"
FT   VAR_SEQ         37
FT                   /note="K -> KVKFCSCCPGWSAMARSWLTATSATQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16303743"
FT                   /id="VSP_023825"
FT   VAR_SEQ         204..234
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_023826"
FT   VARIANT         331
FT                   /note="R -> Q (in dbSNP:rs1127800)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031173"
FT   VARIANT         338
FT                   /note="A -> V (in dbSNP:rs6682)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.2"
FT                   /id="VAR_031174"
FT   MUTAGEN         84
FT                   /note="Y->S: Significantly decreased carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:20724479"
FT   MUTAGEN         88
FT                   /note="W->A: Significantly decreased carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:20724479"
FT   MUTAGEN         110
FT                   /note="W->A: Significantly decreased carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:20724479"
FT   MUTAGEN         261
FT                   /note="Y->S: Significantly decreased carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:20724479"
FT   MUTAGEN         277
FT                   /note="W->A: No noticeable effect."
FT                   /evidence="ECO:0000269|PubMed:20724479"
FT   MUTAGEN         302
FT                   /note="Y->S: Significantly decreased carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:20724479"
FT   CONFLICT        335
FT                   /note="D -> G (in Ref. 4; BAB55316)"
FT                   /evidence="ECO:0000305"
FT   HELIX           45..47
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           57..63
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   TURN            70..73
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          81..86
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           91..99
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           100..102
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          111..117
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          120..124
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           126..128
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           131..140
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          141..143
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          149..152
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           157..164
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           167..184
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          188..192
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           194..196
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           202..218
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          222..227
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   TURN            233..235
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           243..249
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   TURN            250..252
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          254..258
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           275..285
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           292..294
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          295..307
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   TURN            308..311
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          312..316
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           318..328
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   TURN            336..339
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          340..347
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   TURN            348..350
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          351..356
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           360..373
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   STRAND          376..380
FT                   /evidence="ECO:0007829|PDB:3BXW"
FT   HELIX           387..392
FT                   /evidence="ECO:0007829|PDB:3BXW"
SQ   SEQUENCE   393 AA;  44941 MW;  FFD5E67C20AF69B4 CRC64;
     MRTLFNLLWL ALACSPVHTT LSKSDAKKAA SKTLLEKSQF SDKPVQDRGL VVTDLKAESV
     VLEHRSYCSA KARDRHFAGD VLGYVTPWNS HGYDVTKVFG SKFTQISPVW LQLKRRGREM
     FEVTGLHDVD QGWMRAVRKH AKGLHIVPRL LFEDWTYDDF RNVLDSEDEI EELSKTVVQV
     AKNQHFDGFV VEVWNQLLSQ KRVGLIHMLT HLAEALHQAR LLALLVIPPA ITPGTDQLGM
     FTHKEFEQLA PVLDGFSLMT YDYSTAHQPG PNAPLSWVRA CVQVLDPKSK WRSKILLGLN
     FYGMDYATSK DAREPVVGAR YIQTLKDHRP RMVWDSQASE HFFEYKKSRS GRHVVFYPTL
     KSLQVRLELA RELGVGVSIW ELGQGLDYFY DLL
//
